Literature DB >> 26093041

In-vivo pharmacology of Trace-Amine Associated Receptor 1.

Vincent M Lam1, Stefano Espinoza2, Andrey S Gerasimov3, Raul R Gainetdinov4, Ali Salahpour5.   

Abstract

Trace-amines (TAs) are endogenous amines that are implicated in several physiological processes including modulation of aminergic neurotransmission. These compounds exert their effect by activating a class of G protein-coupled receptors termed Trace-Amine Associated Receptors (TAARs), where TAAR1 is the only human receptor that has been shown to bind endogenous TAs. Most of the studies have focused on studying the role of TAAR1 on modulation of the dopamine transmission. These studies indicate that TAAR1 is a negative regulator of dopamine transmission making TAAR1 a novel target for neuropsychiatric disorders that arises from dopamine dysfunction such as schizophrenia. This review discusses the unique pharmacology of TAAR1 with the major focus on the physiological role of TAAR1 and its modulation of dopamine transmission.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine; Neurological disorders; TAAR1; Trace-amines

Mesh:

Substances:

Year:  2015        PMID: 26093041     DOI: 10.1016/j.ejphar.2015.06.026

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Authors:  Aurelia Vattai; Elif Akyol; Christina Kuhn; Simone Hofmann; Helene Heidegger; Franz von Koch; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Christine Spitzweg; Bettina Toth; Sven Mahner; Udo Jeschke; Nina Ditsch
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-13       Impact factor: 4.553

2.  Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.

Authors:  Guido Galley; Angélica Beurier; Guillaume Décoret; Annick Goergler; Roman Hutter; Susanne Mohr; Axel Pähler; Philipp Schmid; Dietrich Türck; Robert Unger; Katrin Groebke Zbinden; Marius C Hoener; Roger D Norcross
Journal:  ACS Med Chem Lett       Date:  2015-12-30       Impact factor: 4.345

3.  Dopamine Evokes a Trace Amine Receptor-dependent Inward Current that is Regulated by AMP Kinase in Substantia Nigra Dopamine Neurons.

Authors:  Wei Yang; Adam C Munhall; Steven W Johnson
Journal:  Neuroscience       Date:  2019-12-26       Impact factor: 3.590

4.  New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.

Authors:  Lorenza Bellusci; Annunziatina Laurino; Martina Sabatini; Simona Sestito; Paola Lenzi; Laura Raimondi; Simona Rapposelli; Francesca Biagioni; Francesco Fornai; Alessandra Salvetti; Leonardo Rossi; Riccardo Zucchi; Grazia Chiellini
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

5.  Behavioral Effects of a Potential Novel TAAR1 Antagonist.

Authors:  Vincent M Lam; Catharine A Mielnik; Corey Baimel; Pieter Beerepoot; Stefano Espinoza; Ilya Sukhanov; Wendy Horsfall; Raul R Gainetdinov; Stephanie L Borgland; Amy J Ramsey; Ali Salahpour
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

6.  Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.

Authors:  Eileen Tremmel; Simone Hofmann; Christina Kuhn; Helene Heidegger; Sabine Heublein; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Sven Mahner; Nina Ditsch; Udo Jeschke; Aurelia Vattai
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-02-19

7.  Biomolecular Evaluation of Lavandula stoechas L. for Nootropic Activity.

Authors:  Aamir Mushtaq; Rukhsana Anwar; Umar Farooq Gohar; Mobasher Ahmad; Romina Alina Marc Vlaic; Crina Carmen Mureşan; Marius Irimie; Elena Bobescu
Journal:  Plants (Basel)       Date:  2021-06-21

Review 8.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.

Authors:  Yue Pei; Aman Asif-Malik; Juan J Canales
Journal:  Front Neurosci       Date:  2016-04-05       Impact factor: 4.677

9.  TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC.

Authors:  Stavroula Stavrou; Michael Gratz; Eileen Tremmel; Christina Kuhn; Simone Hofmann; Helene Heidegger; Mina Peryanova; Kerstin Hermelink; Stefan Hutter; Bettina Toth; Doris Mayr; Sven Mahner; Udo Jeschke; Aurelia Vattai
Journal:  Endocr Connect       Date:  2018-02       Impact factor: 3.335

10.  Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.

Authors:  Xiaoqun Zhang; Ioannis Mantas; Alexandra Alvarsson; Takashi Yoshitake; Mohammadreza Shariatgorji; Marcela Pereira; Anna Nilsson; Jan Kehr; Per E Andrén; Mark J Millan; Karima Chergui; Per Svenningsson
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.